机构：[1]Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China江苏省人民医院[2]Department of Endocrinology, Peking University First Hospital, #8 Xishiku Street, Beijing, China[3]Department of Endocrinology, West China Medical School, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[4]Department of Endocrinology, Peking University First Hospital, Beijing 100034, China[5]Institute of Diabetes, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu 210009, China[6]Department of Endocrinology, China-Japan Friendship Hospital, Beijing 100029, China[7]Department of Endocrinology, First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi 530021, China[8]Nursing Department, Second XiangyaHospital of Central South University, Changsha, Hunan 410011, China[9]Department of Endocrinology, Metabolism, First Affiliated Hospital of Kunming Medical College, Kunming, Yunnan 650032, China昆明医科大学附属第一医院[10]UMass Medical School, 364 Plantation Street LRB 222, Worcester
Background The prevalence of type 2 diabetes in China is increasing rapidly. Appropriate management of glycemia, blood pressure and dyslipidemia in this population is a major public health concern. Objective The aim of this study was to assess metabolic control including glycated hemoglobin A(1c) (HbA(1c)), blood pressure (BP) and low density lipoprotein cholesterol (LDL-c), in a large sample of patients with type 2 diabetes in China and to identify factors that correlated with the achievement of HbA(1c), BP and LDL-c goals (ABCs). Method A nationwide survey was conducted in 50 medical centres across China from April to July of 2010. Baseline information on demographics, medical history, HbA(1c), BP and LDL-c levels were measured in 5961 patients with type 2 diabetes. Results Mean age, body mass index (BMI) and HbA(1c) were 59.5 +/- 1.3 years, 24.5 +/- 4.1 kg/m(2) and 8.3 +/- 2.2%, respectively. With respect to generally accepted ABC treatment goals, 35.2% of participants had HbA(1c) <7%; 35.5% had BP<140/80 mmHg, and 45.1% had LDL-c<100 mg/dl. The proportion of patients who met all three targets was only 5.4%. Logistic regression revealed that smoking (P=0.000), higher BMI (P=0.001) and insulin use (P=0.000) were statistically significant predictors of failing to meet ABC targets. Conclusion The percentage of Chinese patients with type 2 diabetes who met recommended targets for HbA(1c), BP and LDL-c in 2010 was low. Smoking, higher BMI and insulin use were the strongest determinants of failing to meet ABC targets. Copyright (C) 2015 John Wiley & Sons, Ltd.
第一作者机构：[1]Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
通讯作者：
通讯机构：[1]Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China[2]Department of Endocrinology, Peking University First Hospital, #8 Xishiku Street, Beijing, China[*1]Province Hospital on Integration of Chinese and Western Medicine, Nanjing University of Chinese Medicine, #100 Hongshan Road, Qixia District Nanjing 210028 China.[*2]Department of Endocrinology, Peking University First Hospital, #8 Xishiku Street Beijing, 100034 China.
推荐引用方式(GB/T 7714)：
Liu Lin,Lou Qingqing,Guo Xiaohui,et al.Management status and its predictive factors in patients with type 2 diabetes in China: A Nationwide Multicenter Study[J].DIABETES-METABOLISM RESEARCH AND REVIEWS.2015,31(8):811-816.doi:10.1002/dmrr.2757.
APA：
Liu, Lin,Lou, Qingqing,Guo, Xiaohui,Yuan, Li,Shen, Li...&Study Group.(2015).Management status and its predictive factors in patients with type 2 diabetes in China: A Nationwide Multicenter Study.DIABETES-METABOLISM RESEARCH AND REVIEWS,31,(8)
MLA：
Liu, Lin,et al."Management status and its predictive factors in patients with type 2 diabetes in China: A Nationwide Multicenter Study".DIABETES-METABOLISM RESEARCH AND REVIEWS 31..8(2015):811-816
